Home Tags Biofourmis

Tag: Biofourmis

Biofourmis raises 100 million dollars

Biofourmis Raises $100 Million In Series C Funding To Accelerate Global Expansion

Biofourmis, which combines AI-based data analytics and biosensors to monitor the progress of medical treatments, has raised $100 million Series C financing round led by SoftBank Vision Fund 2, with […]
To access this page, watch the live stream and videos on-demand, you must purchase the Free Subscription, Premium Subscription or Premium Subscription (6 months, special rate).
Chugai Biofourmis partnership

Chugai and Biofourmis Collaborating to Develop Digital Solution For Objective Assessment of Pain

Chugai Pharmaceutical, one of Japan’s leading research-based pharmaceutical companies and Biofourmis, a Boston-based digital therapeutics company, announced that they have partnered to develop a digital solution for the objective assessment […]
To access this page, watch the live stream and videos on-demand, you must purchase the Free Subscription, Premium Subscription or Premium Subscription (6 months, special rate).
Biofourmis Biovitals Sentinnel for COVID 19 patients

Biofourmis’ AI-Powered Tech Being Used in Remote Monitoring of COVID-19 Patients in Hong Kong

Biofourmis, a developer of digital therapeutics that powers personalized predictive care, announced that its technology is being leveraged in a remote monitoring and disease surveillance program in Hong Kong involving […]
To access this page, watch the live stream and videos on-demand, you must purchase the Free Subscription, Premium Subscription or Premium Subscription (6 months, special rate).
Biofourmis ImagineMIC Partnership

Biofourmis Collaborates with ImagineMIC to Improve Remote Patient Monitoring for Chronic Disease Patients

Biofourmis, a fast-growing global health IT start-up founded in Singapore, and ImagineMIC, a New York-based medical device company formed a partnership to drive improved outcomes and lower healthcare costs for […]
To access this page, watch the live stream and videos on-demand, you must purchase the Free Subscription, Premium Subscription or Premium Subscription (6 months, special rate).
Biofourmis buys Biovotion

Biofourmis Buys Biovotion to Deliver Precise Interventions for Patients with Complex Chronic Conditions

US-based digital therapeutics company Biofourmis has signed an agreement to buy Zurich, Switzerland-based wearable biosensor company Biovotion. The deal consists of all Biovotion’s assets, including the clinical-grade Everion® device and […]
To access this page, watch the live stream and videos on-demand, you must purchase the Free Subscription, Premium Subscription or Premium Subscription (6 months, special rate).
Biofourmis CERSI study

Biofourmis to Partner with Yale University-Mayo Clinic Collaborative Program CERSI

Biofourmis, a global leader in digital therapeutics, has entered a research partnership with Yale University-Mayo Clinic Center of Excellence in Regulatory Science and Innovation (CERSI). The study, which involves patients […]
To access this page, watch the live stream and videos on-demand, you must purchase the Free Subscription, Premium Subscription or Premium Subscription (6 months, special rate).